trending Market Intelligence /marketintelligence/en/news-insights/trending/fX-RT6pytY1bnT9Nf_jaqw2 content esgSubNav
In This List

Sun Pharmaceutical recalls injectible muscle relaxer with glass impurities

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Sun Pharmaceutical recalls injectible muscle relaxer with glass impurities

India's Sun Pharmaceutical Industries Ltd. is recalling four lots of injectible Norcuron from hospitals due to the presence of extremely small glass particles in the medicine.

Norcuron, or vecuronium bromide, is used as part of general anesthesia to relax muscles before surgery or mechanical ventilation.

The company has recalled three lots of the medication in 10-milligram dosage and one lot in the 20-milligram dosage.

Injecting glass particles with other medication can lead to irritation and swelling and in extreme cases may cause blockage and clotting in blood vessels, which can be life-threatening.

The company said it has not received any reports of adverse events related to the recall, which is being conducted with the knowledge of the U.S. Food and Drug Administration.